It has been strongly associated with cognitive decline, vascular inflammation, and blood–brain barrier (BBB) dysfunction, suggesting that PLA2-mediated lipid signaling could be relevant to PD [44,45,46]. The gene discussed is PLA2G1B; the disease is Parkinson disease.